| The role of CXCR3 and its chemokine ligands in skin disease and cancer PT Kuo, Z Zeng, N Salim, S Mattarollo, JW Wells, GR Leggatt Frontiers in medicine 5, 271, 2018 | 154 | 2018 |
| CD155 on tumor cells drives resistance to immunotherapy by inducing the degradation of the activating receptor CD226 in CD8+ T cells M Braun, AR Aguilera, A Sundarrajan, D Corvino, K Stannard, S Krumeich, ... Immunity 53 (4), 805-823. e15, 2020 | 97 | 2020 |
| The role of CXCR3 and its chemokine ligands in skin disease and cancer. Front Med. 2018; 5: 271 PT Kuo, Z Zeng, N Salim, S Mattarollo, JW Wells, GR Leggatt | 8 | 2018 |
| Type I interferon drives a cellular state inert to TCR-stimulation and could impede effective T-cell differentiation in cancer D Corvino, M Batstone, BGM Hughes, T Kempchen, SS Ng, N Salim, ... bioRxiv, 2024.03. 28.587179, 2024 | | 2024 |
| Upregulated 4-1BB (CD137) expression on skin T cells from a mouse model of precancerous skin GR Leggatt, N Salim, S Mattarollo The Journal of Immunology 204 (1_Supplement), 165.27-165.27, 2020 | | 2020 |
